WARWICK, UK / ACCESS Newswire / December 11, 2025 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC; "the Company"; "Moolec"), an innovation-driven company ...
The demand for advanced therapeutics and new drug modalities is expected to explode in the coming decade. For example, more than 2,000 gene therapies and modified cell therapies are currently under ...
The DOE SC program in Advanced Scientific Computing Research (ASCR) hereby announces its interest in basic research to explore potentially high-impact approaches in scientific computing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results